Replacing Essential Passports and Licenses After Certain Emergencies Act or the REPLACE Act This bill requires the President to automatically waive fees to replace critical documents for individuals and households affected by major disasters for which assistance is provided under the Individuals and Households Program.
Public Health and Border Security Act of 2022 This bill requires the Department of Health and Human Services (HHS) to meet conditions related to notification and planning before terminating certain restrictions on imports and individuals entering the United States. Current law authorizes HHS to restrict entries and imports from foreign countries to prevent the introduction of communicable diseases. HHS exercised this authority as part of its COVID-19 response, including to allow for the expulsion of undocumented migrants at the border without any asylum processing. Under this bill, HHS may not terminate the restrictions for (1) at least 60 days after it notifies Congress of the end of the COVID-19 emergency, and (2) at least 30 days after it submits to Congress a plan for addressing the possible influx of migrants or imports resulting from lifting the restrictions.
This symbolic resolution designates July 20, 2022, as "Glioblastoma Awareness Day" to highlight the challenges of glioblastoma, a devastating brain cancer with a very poor survival rate (median survival of 8 months). It encourages public awareness, honors individuals affected by the disease, and supports research efforts like the Glioblastoma Therapeutics Network. The resolution does not create new laws or allocate funds but serves as a formal statement to elevate attention on this aggressive cancer.
Pistol Brace Protection Act This bill removes certain brace-equipped firearms from regulation under certain federal firearms laws. Specifically, under the bill, a pistol that that is equipped with an attachable stabilizing brace (or arm brace) that allows the pistol to be fired with one hand is not a rifle or shotgun subject to regulation (e.g., registration requirements) under the National Firearms Act.
No Free TRIPS Act This bill prohibits the U.S. government from negotiating or concluding any withdrawal from or modification to the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) without explicit authorization from Congress. The TRIPS Agreement is one of several international agreements that led to the creation of the World Trade Organization (WTO). In October 2020, in response to the COVID-19 pandemic, several WTO members proposed a waiver of some TRIPS obligations, including obligations related to national patent laws.
Locating the Inefficiencies of Bureaucratic Edicts to Reform And Transform the Economy Act or the LIBERATE Act This bill establishes the Regulatory Oversight and Review Task Force to evaluate, and provide recommendations for modification, consolidation, harmonization, or repeal of, federal regulations or guidance that impose substantial burdens on U.S. industries or inhibit other economic interests.
Competency-Based Education Act of 2022 or the CBE Act of 2022 This bill creates a framework under which students participating in competency-based education programs may receive federal student aid. Competency-based education refers to education that measures academic progress and attainment (1) by direct assessment of the student's mastery of competencies, (2) by expressing the student's mastery of competencies in terms of equivalent credit or clock hours, or (3) through a combination of both methods in addition to credit or clock hours. The bill also prohibits the Department of Education from enforcing certain regulations related to the definition of credit hour.
This joint resolution requires either the advice and consent of the Senate or an act of Congress before the President may suspend, denounce, or withdraw the United States from the North Atlantic Treaty. No funds may be used to support any efforts to suspend, denounce, or withdraw the United States from the treaty unless (1) both the House and the Senate pass a joint resolution approving withdrawal by a two-thirds vote, or (2) the funds are used pursuant to an act of Congress. The President shall notify Congress in writing of any effort to suspend, denounce, or withdraw from the treaty at least 180 days before taking such action. The President must also consult with Congress before providing such written notification. This joint resolution also authorizes the Senate Legal Counsel and the General Counsel of the House of Representatives to represent Congress in judicial proceedings related to actions that are inconsistent with this resolution.
Kenneth P. Thompson Begin Again Act This bill expands eligibility for the expungement of records related to a first-time drug possession offense. Current law permits expungement for offenders who commit the offense before age 21. This bill permits expungement for offenders who commit the offense at any age.
HRES 1028 is a symbolic House resolution supporting the current legal standard for securities disclosure, which requires companies to share only information investors deem "material" (important to their investment decisions). It opposes new disclosure rules - particularly those focused on environmental, social, and governance (ESG) issues - that would expand beyond the SEC’s core mission of investor protection and market fairness. The resolution argues such changes would burden businesses with costly compliance, create information overload for investors, and distract the SEC from its primary role. It specifically references the decades-old materiality standard established by the 1933 Securities Act and reinforced by the 1976 Supreme Court case *TSC Industries v. Northway*. As a resolution, it does not change law but expresses congressional preference against expanding disclosure requirements.
Modernizing Therapeutic Equivalence Rating Determination Act This bill requires the Food and Drug Administration (FDA) to provide a therapeutic equivalence rating for certain new drug applications if the applicant requests such a rating. Upon request in the application, the FDA must provide such a rating for a new drug application that relies on information from studies not conducted by the applicant and that the applicant does not have a right to reference or use (commonly referred to as a 505(b)(2) application). The FDA must provide the rating no later than 30 days after the application's approval. (A drug is a therapeutic equivalent of another if they produce the same clinical effect and have the same safety profile. Typically, for certain generic drugs, the FDA rates the therapeutic equivalence of that generic drug to another drug, such as the brand name version. Currently, an applicant seeking approval of a drug through a 505(b)(2) application typically only receives an equivalence rating by requesting one from the FDA in a separate petition.)
This resolution calls on the Biden administration and its officials to maintain the sanctions on the repressive regimes in Venezuela and Iran. The resolution also expresses the sense of the House of Representatives that American energy independence should be achieved again for the sake of U.S. national security and the security of U.S. allies; and President Biden should immediately rescind his Executive Orders that prohibit the approval of new leases on federal lands and waters, and should immediately take actions to reestablish American energy independence.
